文献速递乳腺MR

乳腺MRI线性非肿块强化中簇状与非簇状内部强化模式的比较

Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI.
PubMed 文献 · Br J Radiol · 2020-12-17

该研究回顾性分析了2015年1月至2018年4月间598个乳腺MRI线性非肿块强化病灶,其中120个经MRI引导真空辅助活检。结果显示线性非肿块强化病灶中恶性肿瘤占21%,簇状与非簇状内部强化模式的阳性预测值分别为23.1%与19.1%,差异无统计学意义(p=0.597)。作者认为无论内部强化模式或病灶大小,线性非肿块强化在合适人群中可能需行MRI引导真空辅助活检。

要点

  • 线性非肿块强化病灶中恶性肿瘤占21%,其中导管原位癌占活检确诊癌的82%。
  • 簇状与非簇状内部强化模式的阳性预测值分别为23.1%与19.1%,差异无统计学意义(p=0.597)。
  • 病灶<1 cm与≥1 cm的阳性预测值分别为33.3%与18.6%,差异无统计学意义(p=0.157)。

核心结论

  • 线性非肿块强化在本组中恶性肿瘤占21%,簇状与非簇状内部强化模式的阳性预测值无显著差异(23.1% vs 19.1%,p=0.597)。
  • 作者认为无论内部强化模式或病灶大小,线性非肿块强化在合适人群中可能需行MRI引导真空辅助活检。

研究设计与样本

  • 经IRB批准的回顾性研究,纳入2015年1月至2018年4月间598个显示线性非肿块强化且行MRI引导真空辅助活检的病灶。
  • 复习电子病历获取MRI引导真空辅助活检病理、后续手术及临床随访结果,采用卡方检验进行单因素分析。

关键影像表现/征象

  • 120/598(20%)个线性非肿块强化病灶中,簇状内部强化52/120(43%),非簇状内部强化68/120(57%),平均大小1.8 cm(范围0.6-7.6 cm)。
  • 非簇状内部强化中,不均匀强化5/13(38%),均匀强化8/13(62%)。

诊断标准与关键数值

  • MRI引导真空辅助活检确诊癌22/120(18%),其中导管原位癌18/22(82%),浸润性癌4/22(18%)。
  • 31个高风险病灶中3个(10%)术后升级为导管原位癌,总恶性肿瘤为25/120(21%)。
  • 簇状病灶恶性肿瘤12/52(23%),非簇状病灶恶性肿瘤13/68(19%)。
  • 线性非肿块强化簇状内部强化阳性预测值23.1%,非簇状阳性预测值19.1%,差异无统计学意义(p=0.597)。
  • 病灶<1 cm阳性预测值33.3%,≥1 cm阳性预测值18.6%,差异无统计学意义(p=0.157)。

临床应用与阅片要点

  • 作者认为线性非肿块强化伴簇状或非簇状内部强化模式、无论病灶大小,在合适人群中可能需行MRI引导真空辅助活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare positive predictive values (PPVs) of clumped vs non-clumped (homogenous and heterogeneous) internal enhancement on MRI detected linear non-mass enhancement (NME) on MRI-guided vacuum-assisted breast biopsy (MRI-VABB).

METHODS: With IRB (Institutional Review Board) approval, we retrospectively reviewed 598 lesions undergoing MRI-VABB from January 2015 to April 2018 that showed linear NME. We reviewed the electronic medical records for MRI-VABB pathology, any subsequent surgery and clinical follow-up. The X2 test was performed for univariate analysis.

RESULTS: There were 120/598 (20%) linear NME MRI-VABB lesions with clumped (52/120, 43%) vs non-clumped (68/120, 57%) internal enhancement, average size 1.8 cm (range 0.6-7.6 cm). On MRI-VABB, cancer was identified in 22/120 (18%) lesions, ductal carcinoma in situ (DCIS) was found in 18/22 (82%) and invasive cancer in 4 (18%). 3/31 (10%) high-risk lesions upgraded to DCIS at surgery, for a total of 25/120 (21%) malignancies. Malignancy was found in 12/52 (23%) clumped lesions and in 13/68 (19%) of non-clumped lesions that showed heterogeneous (5/13, 38%) or homogenous (8/13, 62%) internal enhancement. The PPV of linear NME with clumped internal enhancement (23.1%) was not significantly different from the PPV of non-clumped linear NME (19.1%) (p = 0.597). The PPV of linear NME lesions <1 cm (33.3%) was not significantly different from the PPV of lesions ≥1 cm (18.6%) (p = 0.157).

CONCLUSIONS: Linear NME showed malignancy in 21% of our series. Linear NME with clumped or non-clumped internal enhancement patterns, regardless of lesion size, might need to undergo MRI-VABB in appropriate populations.

ADVANCES IN KNOWLEDGE: Evaluation of linear NME lesions on breast MRI focuses especially on internal enhancement pattern.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen ST, Covelli J, Okamoto S, et al. Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI. Br J Radiol. 2020. PMID: 33332980. doi:10.1259/bjr.20201166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。